Physician profile
Aaron C Eubanks
NPI 1144422726
$5,103.01
in general payments reported to CMS, 2019-2025
9 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $508 · 2021: $1,214 · 2022: $723 · 2023: $1,588 · 2024: $427 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,205.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $4,082.98 | 2019-2025 | Tfn-Advance, Emphasys, Inhance |
| Stryker Corporation | $754.49 | 2019-2023 | Mako, Insignia |
| Pylant Medical | $69.73 | 2025 | |
| Axogen | $68.17 | 2023 | Avance Nerve Graft |
| Ermi LLC | $40.49 | 2019 | |
| Novo Nordisk INC | $30.33 | 2019 | |
| Smith+Nephew, INC. | $30.15 | 2023 | Bone Anchors With Arthroscopic Delivery System |
| Bioventus LLC | $14.07 | 2021 | |
| Merck Sharp & Dohme LLC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Eubanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.